Clinical Trial Update: Cardiometabolic Benefit of Reducing Iatrogenic Hyperinsulinemia Using Insulin Adjunctive Therapy in Type 1 Diabetes [EARLY_Phase 1]

View source ↗

Summary

An early-phase study assessing whether insulin adjunctive therapy can reduce iatrogenic hyperinsulinemia in Type 1 Diabetes Mellitus and Maturity-Onset Diabetes…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Maturity-onset Diabetes of the Young
• Type 1 Diabetes Mellitus

Drugs mentioned

• Insulin adjunctive therapy

Snippet

Sponsor: Vanderbilt University Medical Center | Conditions: Type 1 Diabetes Mellitus, Glucokinase-Maturity Onset Diabetes of the Young (GCK-MODY) | EARLY_Phase 1 | Status: RECRUITING